Advances in Oncology reviews the year’s most important findings and updates within the field in order to provide practicing oncologists with the current clinical information they need to improve patient outcomes. A distinguished editorial board, led by Dr. Leonidas C. Platanias, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in oncology inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care.
Key Features
-
Contains 25 articles on such topics as de-escalation therapy for HPV-associated oropharyngeal cancer; management of in-transit metastatic melanoma; rare gynecologic tumors; pediatric lymphoma: advances with an eye on disparities; the microbiome and CNS tumors; adjuvant therapy for patients with high-risk urothelial cancer following surgery; targeting the RAS gene for treatment of GI cancers; and more.
-
Provides in-depth, clinical reviews in oncology, providing actionable insights for clinical practice.
-
Presents the latest information in the field under the leadership of an experienced editorial team. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.
Author Information
Edited by Leonidas C. Platanias, M.D., Ph.D, Director, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Professor of Medicine (Hematology and Oncology) and Biochemistry and Molecular Genetics, USA
SECTION I: RADIATION ONCOLOGY
De-escalation for Human Papillomavirus–Associated Oropharyngeal Cancer: A Comprehensive Review
Treatment of Endometrial Cancer: Updates and Future Directives
SECTION II: SURGICAL ONCOLOGY
Remote Telemonitoring and Telehealth in Surgical Oncology
Management of In-Transit Metastatic Melanoma
Contemporary Management of Merkel Cell Carcinoma
SECTION III: GYNECOLOGIC ONCOLOGY
Mitogen-Activated Protein Kinase Driven Rare Gynecologic Cancers and Evolving Therapeutic Targets
Advances in Cervical Cancer
SECTION IV: PEDIATRIC ONCOLOGY
Advances in Pediatric Hodgkin Lymphoma with an Eye on Disparities and Vulnerable Populations
SECTION V: NEURO-ONCOLOGY
Advances in Blood-Brain Barrier Disruption to Facilitate Drug Delivery for Infiltrative Gliomas
Updates on Role for and Efficacy of Laser Interstitial Thermal Therapy in the Management of Brain Tumors
The Microbiome and Central Nervous System Tumors
SECTION VI: HEMATOLOGICAL
ONCOLOGY Moving Toward a Chemotherapy-Free Approach for Philadelphia-Chromosome>Positive Acute Lymphoblastic Leukemia
Inherited Predisposition to Hematopoietic
Malignancies: Advances Made in the Diagnosis and Management of Hereditary Hematopoietic Malignancies in the Era of Next-Generation Sequencing Technologies
SECTION VII: URO-ONCOLOGY
The Future of Radioligand Therapies in Metastatic Castrate-Resistant Prostate Cancer
The Future of Antibody–Drug Conjugates in Urothelial Cancer: New Indications and Novel Targets
SECTION VIII: GASTROINTESTINAL
ONCOLOGY Targeting Rat Sarcoma Viral Oncogene Homolog for Treatment of Gastrointestinal Cancers
Recent Clinical Advances in Rare Gastrointestinal Tumors: Anal, Small Intestine, and Appendix Cancers
Gastrointestinal Cancers and the Link to the Microbiome